Calendar

Week of Apr 6, 2026

Apr 8, 2026approval90d agoVALPROIC ACID — FDA approvalVALPROIC ACID

Sponsor: BIONPHARMA. Form: CAPSULE. Route: ORAL

full page →VALPROIC ACID →fda approvals ↗

Apr 8, 2026approval90d agoONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE (ONDANSETRON HYDROCHLORIDE) — FDA approvalDR REDDYS LABORATORIES LTD

Sponsor: HIKMA FARMACEUTICA. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Apr 8, 2026approval90d agoONDANSETRON HYDROCHLORIDE — FDA approvalRedHill Biopharma Ltd.

Sponsor: HIKMA FARMACEUTICA. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Apr 8, 2026approval90d agoINGREZZA SPRINKLE (VALBENAZINE TOSYLATE) — FDA approvalVALBENAZINE TOSYLATE

Sponsor: NEUROCRINE. Form: CAPSULE. Route: ORAL

full page →VALBENAZINE TOSYLATE →fda approvals ↗

Apr 8, 2026approval90d agoHALOPERIDOL — FDA approvalHALOPERIDOL

Sponsor: AIPING PHARM INC. Form: TABLET. Route: ORAL

full page →HALOPERIDOL →fda approvals ↗

Apr 8, 2026approval90d agoLEVETIRACETAM — FDA approvalAprecia Pharmaceuticals LLC

Sponsor: CHARTWELL MOLECULAR. Form: SOLUTION. Route: ORAL

full page →fda approvals ↗

Apr 8, 2026approval90d agoOFLOXACIN — FDA approvalOFLOXACIN

Sponsor: MICRO LABS. Form: SOLUTION/DROPS. Route: OPHTHALMIC

full page →OFLOXACIN →fda approvals ↗

Apr 8, 2026approval90d agoPROGESTERONE — FDA approvalPROGESTERONE

Sponsor: GLENMARK PHARMS LTD. Form: INSERT. Route: VAGINAL

full page →PROGESTERONE →fda approvals ↗

Apr 8, 2026approval90d agoELTROMBOPAG OLAMINE — FDA approvalAmneal Pharmaceuticals, Inc.

Sponsor: ZENARA. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Apr 8, 2026grant90d agoWASHINGTON UNIVERSITY — Transcriptomic Signatures of Ischemic Stroke: Unlocking Human-Specific Target...

NS grant. $231,264. PI: Destiny Hooper

full page →nih reporter ↗

Apr 8, 2026grant90d agoUNIVERSITY OF PITTSBURGH AT PITTSBURGH — Development of full thickness human skin model for investigating the mechanis...

AI grant. $556,457. PI: Asim Ejaz

full page →nih reporter ↗

Apr 8, 2026grant90d agoALBERT EINSTEIN COLLEGE OF MEDICINE — Restoring Cognitive Flexibility After Adolescent Cocaine Exposure Using Psilo...Albert Einstein College of Medicine

DA grant. $50,114. PI: Julia Rose Benville

full page →nih reporter ↗

Apr 8, 2026grant90d agoTEMPLE UNIV OF THE COMMONWEALTH — Genetic method to selectively lesion axons or prune axonal terminals

NS grant. $237,750. PI: George M Smith

full page →nih reporter ↗

Apr 8, 2026grant90d agoINDIANA UNIVERSITY INDIANAPOLIS — DLK1 Promotes Tumorigenesis and is a Biomarker for MPNST

NS grant. $613,912. PI: David W Clapp

full page →nih reporter ↗

Apr 8, 2026grant90d agoBECKMAN RESEARCH INSTITUTE/CITY OF HOPE — Role and regulation of methylarginine effector TDRD3 in T cell immunityCity of Hope

AI grant. $794,183. PI: Zuoming Sun

full page →nih reporter ↗

Apr 8, 2026grant90d agoCARNEGIE-MELLON UNIVERSITY — Somatostatin neurons and learning

NS grant. $455,645. PI: ALISON L BARTH

full page →nih reporter ↗

Apr 8, 2026grant90d agoUNIVERSITY OF PITTSBURGH AT PITTSBURGH — A Day in the Life of the Human Brain: Investigating the Dynamic Interrelation...

MH grant. $1,004,971. PI: AVNIEL S GHUMAN

full page →nih reporter ↗

Apr 8, 2026grant90d agoYALE UNIVERSITY — Serotype re-emergence and vaccine impact in the era of next-generation pneumo...

AI grant. $792,513. PI: Daniel Martin Weinberger

full page →nih reporter ↗

Apr 8, 2026grant90d agoUNIVERSITY OF KANSAS MEDICAL CENTER — Pre-Clinical Evaluation of a Highly Selective SMARCA2 Degrader in Therapy-Res...University of Kansas Medical Center

CA grant. $398,544. PI: Priyanka Sharma

full page →nih reporter ↗

Apr 8, 2026grant90d agoSRI INTERNATIONAL — Development and Support of the Pathway Tools SoftwareSRI International

AI grant. $1,219,508. PI: PETER D KARP

full page →nih reporter ↗

Apr 8, 2026grant90d agoUNIV OF NORTH CAROLINA CHAPEL HILL — MASTL Kinase in DNA Repair and Treatment Resistance in Oral Squamous Cell Car...

DE grant. $42,358. PI: Odjo Gouttia

full page →nih reporter ↗

Apr 8, 2026grant90d agoUNIVERSITY OF TX MD ANDERSON CAN CTR — Proline tRNA biogenesis as oncogenic drivers and therapeutic target in T cell...

CA grant. $473,372. PI: Palaniraja Thandapani

full page →nih reporter ↗

Apr 8, 2026grant90d agoHEALTHPARTNERS INSTITUTE — Data-driven Development of Clinically Translatable EHR-Based Models to Estima...

MH grant. $199,747. PI: Kathleen Miley

full page →nih reporter ↗

Apr 8, 2026grant90d agoFRED HUTCHINSON CANCER CENTER — Investigating the impact of type I IFN signaling on regulatory T cell functio...

AI grant. $49,343. PI: Lakshmi S Warrier

full page →nih reporter ↗

Apr 8, 2026grant90d agoSTANFORD UNIVERSITY — Advancing iPSC-derived Thymic Epithelial Cells as Cell Therapy for T Cell Imm...Stanford University

AI grant. $809,250. PI: Katja Gabriele Weinacht

full page →nih reporter ↗

Apr 8, 2026grant90d agoUT SOUTHWESTERN MEDICAL CENTER — Mentoring in Translational Research in Inflammatory Skin Disease

AR grant. $123,108. PI: Tamia Alisha Harris-Tryon

full page →nih reporter ↗

Apr 9, 2026approval89d agoMULTIPLE VITAMINS INJECTION ADULT (ALPHA-TOCOPHEROL ACETATE) — FDA approvalMULTIPLE VITAMINS INJECTION ADULT

Sponsor: APOTEX. Form: SOLUTION. Route: INTRAVENOUS

full page →MULTIPLE VITAMINS INJECTION ADULT →fda approvals ↗

Apr 9, 2026approval89d agoVABYSMO (FARICIMAB-SVOA) — FDA approvalfaricimab

Sponsor: GENENTECH INC. Form: INJECTABLE. Route: INTRAVITREAL

full page →faricimab →fda approvals ↗

Apr 9, 2026approval89d agoFOSFOMYCIN TROMETHAMINE — FDA approvalFOSFOMYCIN TROMETHAMINE

Sponsor: AUCTA. Form: FOR SOLUTION. Route: ORAL

full page →FOSFOMYCIN TROMETHAMINE →fda approvals ↗

Apr 9, 2026approval89d agoDILTIAZEM HYDROCHLORIDE — FDA approvalBausch Health US LLC

Sponsor: ACTAVIS LABS FL INC. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →fda approvals ↗

Apr 9, 2026approval89d agoDOXYCYCLINE HYCLATE — FDA approvalPolyPid Ltd.

Sponsor: IMPAX LABS INC. Form: TABLET, DELAYED RELEASE. Route: ORAL

full page →fda approvals ↗

Apr 9, 2026approval89d agoDOXYCYCLINE HYCLATE — FDA approvalPolyPid Ltd.

Sponsor: IMPAX LABS INC. Form: TABLET, DELAYED RELEASE. Route: ORAL

full page →fda approvals ↗

Apr 9, 2026approval89d agoDOXYCYCLINE HYCLATE — FDA approvalPolyPid Ltd.

Sponsor: IMPAX LABS INC. Form: TABLET, DELAYED RELEASE. Route: ORAL

full page →fda approvals ↗

Apr 9, 2026approval89d agoDOXYCYCLINE HYCLATE — FDA approvalPolyPid Ltd.

Sponsor: IMPAX LABS INC. Form: TABLET, DELAYED RELEASE. Route: ORAL

full page →fda approvals ↗

Apr 9, 2026approval89d agoDEFLAZACORT — FDA approvalAmneal Pharmaceuticals, Inc.

Sponsor: UPSHER SMITH LABS. Form: SUSPENSION. Route: ORAL

full page →fda approvals ↗

Apr 9, 2026approval89d agoDULOXETINE HYDROCHLORIDE — FDA approvalduloxetine hydrochloride DR

Sponsor: ALEMBIC. Form: CAPSULE, DELAYED REL PELLETS. Route: ORAL

full page →duloxetine hydrochloride DR →fda approvals ↗

Apr 9, 2026approval89d agoLAMOTRIGINE — FDA approvalLAMOTRIGINE

Sponsor: AUROBINDO PHARMA. Form: TABLET. Route: ORAL

full page →LAMOTRIGINE →fda approvals ↗

Apr 9, 2026approval89d agoLAMOTRIGINE — FDA approvalLAMOTRIGINE

Sponsor: AUROBINDO PHARMA. Form: TABLET. Route: ORAL

full page →LAMOTRIGINE →fda approvals ↗

Apr 9, 2026approval89d agoMESNA — FDA approvalMESNA

Sponsor: RISING. Form: INJECTABLE. Route: INTRAVENOUS

full page →MESNA →fda approvals ↗

Apr 9, 2026approval89d agoONUREG (AZACITIDINE) — FDA approvalBristol-Myers Squibb Co

Sponsor: BRISTOL. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Apr 9, 2026approval89d agoLEVETIRACETAM — FDA approvalAprecia Pharmaceuticals LLC

Sponsor: CHARTWELL RX. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →fda approvals ↗

Apr 9, 2026approval89d agoCOSOPT PF (DORZOLAMIDE HYDROCHLORIDE) — FDA approvalCosopt

Sponsor: THEA PHARMA. Form: SOLUTION/DROPS. Route: OPHTHALMIC

full page →Cosopt →fda approvals ↗

Apr 9, 2026approval89d agoLAMOTRIGINE — FDA approvalTorrent Pharma Inc

Sponsor: UNICHEM LABS LTD. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Apr 9, 2026approval89d agoREZENOPY (NALOXONE HYDROCHLORIDE) — FDA approvalnaloxone hydrochloride

Sponsor: SCIENTURE. Form: SPRAY. Route: NASAL

full page →naloxone hydrochloride →fda approvals ↗

Apr 9, 2026approval89d agoMULTIPLE VITAMINS INJECTION ADULT (ALPHA-TOCOPHEROL ACETATE) — FDA approvalMULTIPLE VITAMINS INJECTION ADULT

Sponsor: APOTEX. Form: SOLUTION. Route: INTRAVENOUS

full page →MULTIPLE VITAMINS INJECTION ADULT →fda approvals ↗

Apr 9, 2026approval89d agoDOXYCYCLINE HYCLATE — FDA approvalDOXYCYCLINE HYCLATE

Sponsor: RISING. Form: TABLET, DELAYED RELEASE. Route: ORAL

full page →DOXYCYCLINE HYCLATE →fda approvals ↗

Apr 9, 2026approval89d agoDOXYCYCLINE HYCLATE — FDA approvalDOXYCYCLINE HYCLATE

Sponsor: RISING. Form: TABLET, DELAYED RELEASE. Route: ORAL

full page →DOXYCYCLINE HYCLATE →fda approvals ↗

Apr 9, 2026approval89d agoDOXYCYCLINE HYCLATE — FDA approvalDOXYCYCLINE HYCLATE

Sponsor: RISING. Form: TABLET, DELAYED RELEASE. Route: ORAL

full page →DOXYCYCLINE HYCLATE →fda approvals ↗

Apr 9, 2026approval89d agoDOXYCYCLINE HYCLATE — FDA approvalDOXYCYCLINE HYCLATE

Sponsor: RISING. Form: TABLET, DELAYED RELEASE. Route: ORAL

full page →DOXYCYCLINE HYCLATE →fda approvals ↗

Apr 9, 2026grant89d agoEASTERN WASHINGTON UNIVERSITY — Unraveling the Biosynthesis of Aromatic Virulence Factors in Pseudomonas aeru...

AI grant. $470,978. PI: Benjamin Robert Lundgren

full page →nih reporter ↗

← prev

page 1 of 7

Week of Apr 6, 2026